Balakrishnan Gurushankari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Balakrishnan Gurushankari has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Gomathi Shankar
Department of Surgery, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
3 shared publications - Mahalakshmy Thulasingam
Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
3 shared publications - Nivedita Nanda
Department of Biochemistry, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
3 shared publications - Tp Elamurugan
Department of General Surgery, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
3 shared publications - Vikram Kate
Department of Surgery, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India
3 shared publications - Hemamalini Raghuraman
Department of Surgery, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India
2 shared publications
Latest Publications
- 3 September 2025
- Published by Elsevier in Journal of Gastrointestinal Surgery
- p. 102213
Anomalous Origin of Cystic Artery- Clinical Caution in the Era of Minimally Invasive Surgery
- 3 September 2025
- Published by Elsevier in Journal of Gastrointestinal Surgery
- p. 102213
Anomalous Origin of Cystic Artery- Clinical Caution in the Era of Minimally Invasive Surgery
- 10 August 2024
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 41 (3) , 429-437
Development of Panel of Three-Dimensional Biomarkers to Identify Gastric Carcinoma and Precancerous Lesions of the Stomach - An Analytical Cross-Sectional Study
Serological biomarkers have a predictive potential for gastric cancer (GC) and can be classified into three dimensions: stomach-specific biomarkers, GC-related environmental factors, and cancer-associated biomarkers. Inflammation impacts multiple serum markers, and relying on a single marker limits diagnostic accuracy. Combining multiple predictive markers improves GC detection. This study aimed to assess the association and combined diagnostic accuracy of a three-dimensional biomarkers panel in GC patients. Eligible patients were recruited into three groups: GC, precancerous conditions/lesions, and controls. The primary outcome was to assess the association and diagnostic accuracy of three-dimensional biomarkers in identifying GC and precancerous conditions/lesions. The panel constituted stomach-specific markers (Pepsinogen I, Pepsinogen II, Pepsinogen I & II ratio, Trefoil factor 3, Gastrin 17), GC-related environmental factors (Blood Group Antigen Binding Adhesin A, H. pylori IgG), and cancer-associated biomarkers (Carbohydrate Antigen 19.9, Carbohydrate Antigen 125 and Osteopontin). A total of 228 patients, 76 in each group, were enrolled. The combination of all three-dimensional biomarkers showed a high discriminatory ability for diagnosing GC with AUC of 0.938, sensitivity 94.7%, specificity 81.6% and precancerous conditions/lesions with AUC 0.951, sensitivity 93.4%, specificity 92.1%. Among the three-dimensional biomarkers, the combination of TFF3, H. pylori and CA125 demonstrated a high sensitivity in identifying GC, while the combination of PGI, H. pylori, and CA125 exhibited the highest sensitivity in identifying precancerous conditions/lesions. These results emphasize that combined three-dimensional biomarkers showed good discrimination and could be used as a screening panel for diagnosing GC and precancerous conditions/lesions.
- 10 August 2024
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 41 (3) , 429-437
Development of Panel of Three-Dimensional Biomarkers to Identify Gastric Carcinoma and Precancerous Lesions of the Stomach - An Analytical Cross-Sectional Study
Serological biomarkers have a predictive potential for gastric cancer (GC) and can be classified into three dimensions: stomach-specific biomarkers, GC-related environmental factors, and cancer-associated biomarkers. Inflammation impacts multiple serum markers, and relying on a single marker limits diagnostic accuracy. Combining multiple predictive markers improves GC detection. This study aimed to assess the association and combined diagnostic accuracy of a three-dimensional biomarkers panel in GC patients. Eligible patients were recruited into three groups: GC, precancerous conditions/lesions, and controls. The primary outcome was to assess the association and diagnostic accuracy of three-dimensional biomarkers in identifying GC and precancerous conditions/lesions. The panel constituted stomach-specific markers (Pepsinogen I, Pepsinogen II, Pepsinogen I & II ratio, Trefoil factor 3, Gastrin 17), GC-related environmental factors (Blood Group Antigen Binding Adhesin A, H. pylori IgG), and cancer-associated biomarkers (Carbohydrate Antigen 19.9, Carbohydrate Antigen 125 and Osteopontin). A total of 228 patients, 76 in each group, were enrolled. The combination of all three-dimensional biomarkers showed a high discriminatory ability for diagnosing GC with AUC of 0.938, sensitivity 94.7%, specificity 81.6% and precancerous conditions/lesions with AUC 0.951, sensitivity 93.4%, specificity 92.1%. Among the three-dimensional biomarkers, the combination of TFF3, H. pylori and CA125 demonstrated a high sensitivity in identifying GC, while the combination of PGI, H. pylori, and CA125 exhibited the highest sensitivity in identifying precancerous conditions/lesions. These results emphasize that combined three-dimensional biomarkers showed good discrimination and could be used as a screening panel for diagnosing GC and precancerous conditions/lesions.
- 1 December 2023
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 408 (1) , 1-10
Role of specific nutritional biomarkers in predicting post-operative complications among patients undergoing elective abdominal surgery
Purpose Nutritional biomarkers like serum prealbumin, transferrin, retinol-binding protein (RBP), C-reactive protein (CRP), leptin, and insulin-like growth factor 1 (IGF1) have the inherent ability to diagnose undernutrition objectively before it is clinically manifested. The primary objective of the study was to evaluate the diagnostic efficacy of the specific nutritional biomarkers in predicting post-operative complications. Methods A prospective cohort study was conducted in the department of surgery and included all patients aged 18 years and above who underwent elective abdominal surgery. Demographic details and clinical and surgical details were documented from the case records. Nutritional biomarker assay was done at admission. The post-operative complications occurring until discharge were graded using the Clavien-Dindo classification. The diagnostic accuracy of the specific nutritional biomarkers in predicting post-operative complications was assessed. Results A total of 320 patients were included in the study. Of these, 126 (39.38%) developed post-operative complications. Major complications accounted for 19.05% of the complications, while 80.95% were minor complications. Patients with blood prealbumin level less than 17.287 mg/dL had a higher incidence of complications (p < 0.001). Serum transferrin levels less than 168.04 mg/dL and IGF1 levels less than < 44.51 ng/ml showed increased incidence of complications (p < 0.001). The AUC was found to be the highest for serum IGF1 with 0.7782. Sensitivity was equally high for IGF1 and serum transferrin, with 76.98% for the former and 76.19% for the latter. Conclusion Specific nutritional biomarkers, like serum prealbumin and transferrin, were efficient in predicting postoperative complications of patients before undergoing elective abdominal surgeries even after adjusting for confounders. This can facilitate preoperative corrective measures to lower the overall postoperative complications.
- 1 December 2023
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 408 (1) , 1-10
Role of specific nutritional biomarkers in predicting post-operative complications among patients undergoing elective abdominal surgery
Purpose Nutritional biomarkers like serum prealbumin, transferrin, retinol-binding protein (RBP), C-reactive protein (CRP), leptin, and insulin-like growth factor 1 (IGF1) have the inherent ability to diagnose undernutrition objectively before it is clinically manifested. The primary objective of the study was to evaluate the diagnostic efficacy of the specific nutritional biomarkers in predicting post-operative complications. Methods A prospective cohort study was conducted in the department of surgery and included all patients aged 18 years and above who underwent elective abdominal surgery. Demographic details and clinical and surgical details were documented from the case records. Nutritional biomarker assay was done at admission. The post-operative complications occurring until discharge were graded using the Clavien-Dindo classification. The diagnostic accuracy of the specific nutritional biomarkers in predicting post-operative complications was assessed. Results A total of 320 patients were included in the study. Of these, 126 (39.38%) developed post-operative complications. Major complications accounted for 19.05% of the complications, while 80.95% were minor complications. Patients with blood prealbumin level less than 17.287 mg/dL had a higher incidence of complications (p < 0.001). Serum transferrin levels less than 168.04 mg/dL and IGF1 levels less than < 44.51 ng/ml showed increased incidence of complications (p < 0.001). The AUC was found to be the highest for serum IGF1 with 0.7782. Sensitivity was equally high for IGF1 and serum transferrin, with 76.98% for the former and 76.19% for the latter. Conclusion Specific nutritional biomarkers, like serum prealbumin and transferrin, were efficient in predicting postoperative complications of patients before undergoing elective abdominal surgeries even after adjusting for confounders. This can facilitate preoperative corrective measures to lower the overall postoperative complications.